Primidone BE study for USFDA submission [Regulatives / Guidelines]

posted by Ramesh Ramalingam  – India, 2018-04-09 05:54 (1383 d 15:47 ago) – Posting: # 18654
Views: 3,943

Dear All,

Till now, USFDA has not issued product specific bioequivalence recommendation to conduct the Primidone BE study. Any one could suggest, what to estimate in the Primidone BE study for USFDA submission, Whether required to estimate parent (Primidone) and metabolite Phenobarbital and phenylethylmalonamide (PEMA) or parent only?


Regards,
Ramesh.R


Edit: Relax; see also this post #9. I deleted your other post which is less than two days old… [Helmut]

Complete thread:

Activity
 Admin contact
21,834 posts in 4,569 threads, 1,554 registered users;
online 8 (0 registered, 8 guests [including 4 identified bots]).
Forum time: Friday 20:41 CET (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5